| pubmed-article:18469640 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C0036983 | lld:lifeskim |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C1272641 | lld:lifeskim |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:18469640 | lifeskim:mentions | umls-concept:C0012000 | lld:lifeskim |
| pubmed-article:18469640 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18469640 | pubmed:dateCreated | 2008-5-12 | lld:pubmed |
| pubmed-article:18469640 | pubmed:abstractText | Emphasis in therapy of human septic shock is shifting towards reliable end points and predictors of survival. Rationale is to study whether the evolution of cardiovascular reactivity in view of the administered doses of norepinephrine is an early predictor of in-hospital survival and to determine the optimal threshold of norepinephrine therapy and its consequences on renal function. | lld:pubmed |
| pubmed-article:18469640 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18469640 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18469640 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18469640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18469640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18469640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18469640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18469640 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18469640 | pubmed:month | May | lld:pubmed |
| pubmed-article:18469640 | pubmed:issn | 1529-8809 | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:PayenDidierD | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:MebazaaAlexan... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:BertonChristi... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:RichéFlorence... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:LaisnéMarie-J... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:KarpatiPeter... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:MateoJoaquimJ | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:BenchekrouneS... | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:NathanCédricC | lld:pubmed |
| pubmed-article:18469640 | pubmed:author | pubmed-author:ChaaraMansour... | lld:pubmed |
| pubmed-article:18469640 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18469640 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:18469640 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18469640 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18469640 | pubmed:pagination | 1188-95 | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:meshHeading | pubmed-meshheading:18469640... | lld:pubmed |
| pubmed-article:18469640 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18469640 | pubmed:articleTitle | Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock. | lld:pubmed |
| pubmed-article:18469640 | pubmed:affiliation | Department of Anesthesiology and Intensive Care, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. | lld:pubmed |
| pubmed-article:18469640 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18469640 | pubmed:publicationType | Clinical Trial | lld:pubmed |
